You are not logged in!

You are not logged in!

You are not logged in!

Egide - CA S1: The USA still recovering - Purchase - Obj.  €1.45 vs. €1.78 - Jar.  +67.7% - 07/22/2022 at 09:56

Egide – CA S1: The USA still recovering – Purchase – Obj. €1.45 vs. €1.78 – Jar. +67.7% – 07/22/2022 at 09:56

This analysis was prepared by GreenSome Finance and published by BOURSORAMA on 07/22/2022 at 09:56:28.

Acting exclusively as a distribution channel, BOURSORAMA has not participated in any way in its development or exercised any discretionary power with regard to its selection. The information contained in this analysis has been transcribed “as is”, without representation or guarantee of any kind. The opinions or estimates expressed therein are those of its authors and do not reflect the point of view of BOURSORAMA. Subject to applicable laws, neither the information contained nor the analyzes expressed therein shall engage BOURSORAMA’s liability. The content of the analysis made available by BOURSORAMA is provided for information purposes only and has no contractual value. It thus constitutes a simple decision-making aid over which the user retains absolute control.

BOURSORAMA is a credit institution governed by French law approved by the French Prudential Control and Resolution Authority (“ACPR”) and by the Financial Markets Authority (“AMF”) as an investment services provider and under the prudential supervision of the European Central Bank (“ECB”).

In accordance with the regulations in force, BOURSORAMA establishes and maintains a policy for managing conflicts of interest and implements administrative and organizational measures to prevent, identify and manage situations of conflicts of interest with regard to the recommendations of investment broadcast. These rules notably contain provisions relating to personal financial transactions in order to ensure that BOURSORAMA employees are not in a situation of conflict of interest when Boursorama disseminates investment recommendations.

The reader is informed that BOURSORAMA has no conflict of interest that could affect the objectivity of the analyzes disseminated. As such, the reader is informed that there is no direct link between the analyzes disseminated and the variable compensation of BOURSORAMA employees. Similarly, there are no financial or capital ties between BOURSORAMA and the issuers concerned, apart from the contractual commitments that may govern the supply of the distribution service.

It is reminded that the entities of the Societe Generale group, to which BOURSORAMA belongs, may carry out transactions on the financial instruments mentioned in this analysis, hold stakes in the companies issuing these financial instruments, act as a market maker, advise , broker, or banker of these instruments, or be represented on the board of directors of these companies. These circumstances cannot in any way affect the objectivity of the analyzes disseminated by BOURSORAMA.

.

Comments

0 comments

Leave a Comment

Your email address will not be published.